Biotools, founded in 1996 with the aim of developing and marketing enzymes and reagents for molecular biology, has focused its efforts in recent years on the research and development of diagnostic and detection kits, mainly based on genomic techniques..

The aim of the company is to develop, manufacture and market recombinant enzymes for molecular biology and other reagents for applications in biotechnology.

1996

Marketing of enzymes produced at the CSIC.

1999

First CDTI support – Production and development in the company`s current laboratories.

2000

The pharmaceutical company Inibsa enters the capital structure of the company, in order to strengthen R & D for the development of diagnostic kits using molecular biology techniques.

2001

Completion of development and registration of an international patent for the protection of a biomolecules stabilisation system and complex reaction mixes based on the gelification technique.

2003

The venture capital fund Najeti Capital enters the company’s capital structure with the objective of completing the earlier process related to the development of diagnostic kits, environmental control kits and identification of alimentary components, as a prelude to the launch of the products on the market.

2006

End of the development of a genomic detection method based on fluorescent probes through PCR in real time.In 2006 Biotools created a new international patent called the Lion-Probes®. This is an independent patent that does not require the utilisation of third-party licenses in order to carry out molecular in-vitro diagnosis.

2007

The venture capital fund Najeti Capital leaves Biotools`s capital structure upon completion of the stipulated partnership term with the company. This year also marks the beginning of the development of microarrays and biochips, and the creation of a new laboratory for this purpose. The company obtained an substantial loan from the CDTI for the execution of this development project.

2009

Sale of the microarrays division.

2010

Signing of an agreement with the Brazilian Ministry of Health to create a network for epidemiological surveillance. Creation of a joint venture for expanding the Biotools brand in India through the company 3B BlackBio.

2010

Creation of the spin-off 2B BlackBio to develop human diagnostic kits through the pyrosequencing technique.

2012

Acquisition of 100% of the company by Inibsa with the aim of promoting the development of new enzymes for diagnosis.

2014

Introduction of a new international patent in the field of development of new thermostable enzymes for use in molecular diagnostics.

SpeedTools - Plasmid DNA Purification Kit